Mariner’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$860M Buy
716,755
+22,894
+3% +$23.4M 0.9% 19
2026
Q1
$638M Buy
693,861
+29,882
+5% +$30.3M 0.74% 22
2025
Q4
$714M Buy
663,979
+18,502
+3% +$17.7M 0.85% 20
2025
Q3
$492M Buy
645,477
+22,124
+4% +$16.5M 0.64% 28
2025
Q2
$486M Buy
623,353
+31,950
+5% +$24.8M 0.7% 23
2025
Q1
$488M Buy
591,403
+27,727
+5% +$23.1M 0.81% 21
2024
Q4
$435M Buy
563,676
+14,911
+3% +$12.3M 0.73% 25
2024
Q3
$486M Buy
548,765
+10,728
+2% +$9.64M 0.86% 18
2024
Q2
$487M Buy
538,037
+19,570
+4% +$15.7M 0.94% 17
2024
Q1
$403M Sell
518,467
-33,000
-6% -$23.5M 0.83% 20
2023
Q4
$321M Buy
551,467
+26,165
+5% +$15.3M 0.76% 22
2023
Q3
$282M Buy
525,302
+22,293
+4% +$11.5M 0.76% 20
2023
Q2
$236M Sell
503,009
-10,014
-2% -$4.2M 0.63% 27
2023
Q1
$176M Buy
513,023
+39,849
+8% +$13.4M 0.51% 35
2022
Q4
$173M Buy
473,174
+29,260
+7% +$10.4M 0.56% 30
2022
Q3
$144M Buy
443,914
+16,297
+4% +$5.16M 0.57% 30
2022
Q2
$139M Buy
427,617
+45,727
+12% +$13.7M 0.57% 33
2022
Q1
$109M Sell
381,890
-30,497
-7% -$7.85M 0.41% 58
2021
Q4
$114M Buy
412,387
+40,743
+11% +$10.3M 0.48% 40
2021
Q3
$85.9M Buy
371,644
+20,152
+6% +$4.97M 0.45% 47
2021
Q2
$80.7M Buy
351,492
+44,210
+14% +$8.88M 0.5% 45
2021
Q1
$57.4M Buy
307,282
+19,921
+7% +$3.9M 0.4% 63
2020
Q4
$48.5M Buy
287,361
+54,104
+23% +$8.08M 0.37% 71
2020
Q3
$34.5M Buy
233,257
+22,301
+11% +$3.45M 0.33% 90
2020
Q2
$34.6M Buy
210,956
+16,960
+9% +$2.6M 0.35% 85
2020
Q1
$26.9M Buy
193,996
+3,449
+2% +$474K 0.34% 84
2019
Q4
$25M Buy
190,547
+27,926
+17% +$3.24M 0.26% 111
2019
Q3
$18.2M Buy
162,621
+10,872
+7% +$1.21M 0.22% 128
2019
Q2
$16.8M Sell
151,749
-2,598
-2% -$306K 0.2% 137
2019
Q1
$20M Buy
154,347
+947
+0.6% +$115K 0.29% 103
2018
Q4
$17.7M Buy
153,400
+69,096
+82% +$7.72M 0.32% 95
2018
Q3
$9.05M Buy
84,304
+8,880
+12% +$888K 0.23% 102
2018
Q2
$6.44M Buy
75,424
+15,291
+25% +$1.26M 0.18% 126
2018
Q1
$4.65M Buy
60,133
+13,908
+30% +$1.12M 0.17% 118
2017
Q4
$3.9M Buy
46,225
+11,161
+32% +$950K 0.15% 122
2017
Q3
$3M Buy
35,064
+2,486
+8% +$204K 0.14% 130
2017
Q2
$2.68M Sell
32,578
-5,363
-14% -$438K 0.13% 137
2017
Q1
$3.19M Buy
37,941
+2,080
+6% +$167K 0.14% 135
2016
Q4
$2.64M Buy
35,861
+166
+0.5% +$12.4K 0.12% 148
2016
Q3
$2.87M Buy
35,695
+5,825
+20% +$466K 0.14% 138
2016
Q2
$2.35M Sell
29,870
-2,681
-8% -$202K 0.13% 150
2016
Q1
$2.34M Buy
32,551
+9,863
+43% +$746K 0.14% 140
2015
Q4
$1.91M Sell
22,688
-7,436
-25% -$617K 0.12% 148
2015
Q3
$2.52M Buy
30,124
+3,631
+14% +$307K 0.11% 158
2015
Q2
$2.21M Buy
26,493
+9,302
+54% +$709K 0.1% 169
2015
Q1
$1.25M Buy
17,191
+2,520
+17% +$179K 0.11% 162
2014
Q4
$1.01M Buy
14,671
+1,369
+10% +$92.4K 0.09% 173
2014
Q3
$863K Sell
13,302
-3,132
-19% -$198K 0.1% 166
2014
Q2
$1.02M Buy
16,434
+516
+3% +$30.8K 0.11% 155
2014
Q1
$937K Buy
15,918
+207
+1% +$11.6K 0.12% 154
2013
Q4
$801K Sell
15,711
-641
-4% -$32.1K 0.1% 173
2013
Q3
$823K Sell
16,352
-35,446
-68% -$1.86M 0.15% 140
2013
Q2
$2.54M Buy
+51,798
New +$2.82M 0.54% 50

Other funds holding LLY

Mariner's LLY Position: Q2 2026 in Review

Mariner increased its Eli Lilly (LLY) stake by 3.3% in Q2 2026, buying an estimated $23.4M and bringing the position to 716,755 shares worth $860M. The position accounts for 0.9% of the portfolio, ranked #19.

Mariner first reported a position in LLY in Q2 2013 and has held it in 53 quarters since. 4,593 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Mariner held 716,755 shares of Eli Lilly worth $860M as of Q2 2026.
  • Mariner bought 22,894 Eli Lilly shares in Q2 2026, an estimated $23.4M.
  • Eli Lilly made up 0.9% of Mariner's portfolio in Q2 2026, its #19 holding.
  • Mariner first reported a position in Eli Lilly in Q2 2013 and has held it in 53 quarters since.
  • 4,593 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Mariner's 13F filing for Q2 2026, filed 13 Aug 2026.